Table 4 Clinical and laboratory characteristics in ICSI cycles, by PCOS phenotype
From: Polycystic ovary syndrome phenotype does not have impact on oocyte morphology
PCOS B (n = 1) was excluded | PCOS A N = 41 | PCOS C N = 31 | PCOS D N = 37 | p value | Adjusted p |
|---|---|---|---|---|---|
Number of ICSI cycles | 77 | 57 | 55 | – | – |
Woman’s age during the ICSI cycle | 29.6 ± 3,3 | 29.0 ± 4.3 | 29.7 ± 3.2 | 0.48 | – |
Protocol: | 0.73 | – | |||
Agonist, n (%) | 38 (49.4) | 29 (50.9) | 24 (43.6) | – | – |
Antagonist, n (%) | 39 (50.6) | 28 (49.1) | 31 (56.4) | – | – |
Number of days of stimulation | 12.9 ± 2.5 | 12.1 ± 2.5 | 12.1 ± 1.9 | 0.15 | – |
Total dose of FSH, IU | 1812 ± 872 | 2016 ± 1076 | 1741 ± 700 | 0.41 | – |
Estradiol on hCG day, pg/mL | 2666 ± 1454 | 2363 ± 1387 | 2382 ± 1206 | 0.42 | – |
Mean number of oocytes retrieved (N) | 12.2 ± 6.0 | 12.1 ± 5.2 | 11.8 ± 6.2 | 0.92 | 0.92 |
Mean number of MII oocytes (n) | 7.8 ± 4.6 | 8.1 ± 3.6 | 7.9 ± 4.8 | 0.91 | 0.98 |
Proportion of MII oocytes, n/N (%) | 602/939 (64.1) | 462/692 (66.8) | 432/648 (66.7) | 0.85 | 0.94 |